| 23.14 0.22 (0.96%) | 07-26 16:00 | |||||||||||||
|
|
| Short term |   |
|||
| Mid term |  |
|||
| Targets | 6-month : | 27.31 | 1-year : | 31.9 |
| Resists | First : | 23.38 | Second : | 27.31 |
| Pivot price | 21.62  |
|||
| Supports | First : | 20.62 | Second : | 18.91 |
| MAs | MA(5) : | 22.77 |
MA(20) : | 21.11 |
| MA(100) : | 19.8 |
MA(250) : | 20.23 |
|
| MACD | MACD : | 0.8 |
Signal : | 0.6 |
| %K %D | K(14,3) : | 90.6 |
D(3) : | 89.6 |
| RSI | RSI(14): 71.3 |
|||
| 52-week | High : | 24.54 | Low : | 17.23 |
Price has closed above its short-term moving average. Short-term moving average is currently above mid-term; and above long-term moving average. From the relationship between price and moving averages: This stock is BULLISH in short-term; and BULLISH in mid-long term.[ AVNS ] has closed below upper band by 20.5%. Bollinger Bands are 173.1% wider than normal. The large width of the bands suggest high volatility as compared to its normal range. The bands have been in this wide range for 10 days. This is a sign that the current trend might continue.
| If tomorrow: | Open lower | Open higher |
| High: | 23.38 - 23.47 | 23.47 - 23.54 |
| Low: | 22.57 - 22.68 | 22.68 - 22.76 |
| Close: | 22.98 - 23.14 | 23.14 - 23.28 |
Avanos Medical, Inc., a medical technology company, focuses on delivering medical device solutions in North America, Europe, the Middle East, Africa, the Asia Pacific, and Latin America. It offers a portfolio of chronic care products that include digestive health products, such as Mic-Key enteral feeding tubes, Corpak patient feeding solutions, and NeoMed neonatal and pediatric feeding solutions; and respiratory health products, such as closed airway suction systems and other airway management devices under the Ballard, Microcuff, and Endoclear brands. The company also provides a portfolio of non-opioid pain solutions, including acute pain products, such as On-Q and ambIT surgical pain pumps, Game Ready cold, and compression therapy systems; and interventional pain solutions, which offers minimally invasive pain-relieving therapies, such as Coolief pain relief therapy. It markets its products directly to hospitals and other healthcare providers, healthcare facilities, and other end-user customers, as well as through third-party wholesale distributors. The company was formerly known as Halyard Health, Inc. and changed its name to Avanos Medical, Inc. in June 2018. Avanos Medical, Inc. was incorporated in 2014 and is headquartered in Alpharetta, Georgia.
Fri, 26 Jul 2024
Three Reasons to Retain Avanos (AVNS) Stock in Your Portfolio - Yahoo Finance
Fri, 26 Jul 2024
Avanos Medical, Inc. (NYSE:AVNS) Shares Acquired by Janney Montgomery Scott LLC - Defense World
Thu, 25 Jul 2024
Avanos Medical (AVNS) to Release Earnings on Wednesday - MarketBeat
Thu, 25 Jul 2024
Avanos Medical (NYSE:AVNS) investors are sitting on a loss of 44% if they invested five years ago - Yahoo Finance
Wed, 24 Jul 2024
AVNS - Avanos Medical, Inc. Latest Stock News & Market Updates - StockTitan
Wed, 24 Jul 2024
Avanos Medical, Inc. to Webcast Conference Call Discussing Second Quarter 2024 Financial Results - Longview News-Journal
| Price to Book Value: P/BV, a ratio used to compare book value to its current market price, to gauge whether a stock is valued properly. |
Outperform |
| Price to Earnings: PE, the ratio for valuing a company that measures its current share price relative to its earnings per share (EPS). |
Underperform |
| Discounted cash flow: DCF, a valuation method used to estimate the value of an investment based on its expected future cash flows. |
Underperform |
| Return on Assets: ROA, indicates how profitable a company is in relation to its total assets, how efficiently uses assets to generate a profit. |
Underperform |
| Return on Equity: ROE, a measure of financial performance calculated by dividing net income by equity. a gauge of profitability and efficiency. |
Underperform |
| Debt to Equity: evaluate financial leverage, reflects the ability of equity to cover outstanding debts in the event of a business downturn. |
Underperform |
|
Exchange:
NYSE
|
|
|
Sector:
Healthcare
|
|
|
Industry:
Medical - Devices
|
|
| Shares Out | 46 (M) |
| Shares Float | 42 (M) |
| Held by Insiders | 2.8 (%) |
| Held by Institutions | 96.9 (%) |
| Shares Short | 845 (K) |
| Shares Short P.Month | 1,050 (K) |
| EPS | -0.03 |
| EPS Est Next Qtrly | 0 |
| EPS Est This Year | 0 |
| EPS Est Next Year | 0 |
| Book Value (p.s.) | 26.57 |
| Profit Margin | -9.2 % |
| Operating Margin | 4.5 % |
| Return on Assets (ttm) | 2.1 % |
| Return on Equity (ttm) | -0.2 % |
| Qtrly Rev. Growth | 4.3 % |
| Gross Profit (p.s.) | 0 |
| Sales Per Share | 14.81 |
| EBITDA (p.s.) | 2.28 |
| Qtrly Earnings Growth | 0 % |
| Operating Cash Flow | 31 (M) |
| Levered Free Cash Flow | 81 (M) |
| PE Ratio | -771.34 |
| PEG Ratio | 2.4 |
| Price to Book value | 0.87 |
| Price to Sales | 1.56 |
| Price to Cash Flow | 34.04 |
| Dividend | 0 |
| Forward Dividend | 0 |
| Dividend Yield | 0% |
| Dividend Pay Date | Invalid DateTime. |
| Ex-Dividend Date | Invalid DateTime. |
|
|
|
|
|
|
|
|
|